STOCK TITAN
  1. Home
  2. News
  3. CRLBF

Cresco Labs Inc. - CRLBF STOCK NEWS

Welcome to our dedicated news page for Cresco Labs (Ticker: CRLBF), a resource for investors and traders seeking the latest updates and insights on Cresco Labs.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Cresco Labs's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Cresco Labs's position in the market.

News
Cresco Labs Reports Fourth Quarter & Full Year 2023 Financial Results Demonstrating Significant Profitability and Cash Flow Improvements
Rhea-AI Summary
Cresco Labs Inc. reports strong financial performance in Q4 2023 with revenue of $188 million and a 12% increase in adjusted gross profit. The company achieved a 3x improvement in full-year Operating Cash Flow and retained the No. 1 share position in key markets. However, there was a 2% decline in revenue due to strategic divestitures. Fiscal Year 2023 highlights include revenue of $771 million, adjusted EBITDA of $174 million, and a net loss of $180 million. The company's focus on the Year-of-the-Core strategy led to margin expansion and positive free cash flow.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.74%
Tags
earnings
-
News
Cresco Labs to Report Fourth Quarter and Annual 2023 Financial Results on March 13, 2024
Rhea-AI Summary
Cresco Labs Inc. announces the reporting of financial results for Q4 and year-end 2023, along with a conference call and webcast to discuss business highlights.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.81%
Tags
conferences earnings
-
News
Cresco Labs Continues Retail Expansion in Pennsylvania with New Gettysburg Store
Rhea-AI Summary
Cresco Labs Inc. opens Sunnyside Gettysburg store in Pennsylvania, expanding its presence in the state. The new location offers a variety of cannabis products to qualified patients and caregivers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.11%
Tags
none
News
Cresco Labs Announces Transfers of Super Voting Shares to Certain Directors
Rhea-AI Summary
Cresco Labs Inc. announces the transfer of Super Voting Shares among directors, enhancing balance and voting power within the company.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
Cresco Labs Promotes Greg Butler to President
Rhea-AI Summary
Cresco Labs Inc. announces the promotion of Greg Butler to President, overseeing all aspects of operations. Butler's experience in leading large iconic brands and his contributions to the development of Cresco Labs are highlighted. The company expresses confidence in its preparedness for the future of the cannabis industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.2%
Tags
none
-
News
Cresco Labs Reports Third Quarter 2023 Financial Results
Rhea-AI Summary
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) reports strong margin and operating cash flow gains, eliminating over $40 million in annualized operating costs. Third quarter revenue reached $191 million, with adjusted gross margin increased by over 480 bps, and adjusted EBITDA margin rose by over 1000 bps. The company retained the No. 1 share position in Illinois, Pennsylvania, and Massachusetts, maintaining the industry's No. 1 bestselling portfolio of branded flower and branded concentrates.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.74%
Tags
earnings
News
Cresco Labs Commends Ohioans on Legalizing Adult-Use Cannabis
Rhea-AI Summary
Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) issued a statement on Ohio's adult-use cannabis legalization, marking the 24th state to do so. The company lauds the move and anticipates a significant impact on the U.S. cannabis market, which is projected to exceed $100 billion annually. Cresco Labs plans to expand its Sunnyside dispensaries and distribution of cannabis brands in Ohio.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.81%
Tags
none
-
News
Cresco Labs to Report Third Quarter 2023 Financial Results on November 15, 2023
Rhea-AI Summary
Cresco Labs, the industry leader in branded cannabis products, will report financial results for the third quarter of 2023 on November 15th. The company will host a conference call and webcast to discuss its financial results and provide key business highlights.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.03%
Tags
conferences earnings
-
News
Cresco Labs Unlocks $32 Million in Non-Dilutive Capital
Rhea-AI Summary
Cresco Labs announces the closing of the sale of its Arizona operation and secures a conventional mortgage on its New York properties.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.16%
Tags
none
News
Cresco Labs Launches Good News Brand in Pennsylvania with New Sweet Troches
Rhea-AI Summary
Cresco Labs launches Good News brand in Pennsylvania with Sweet Troches product
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.6%
Tags
none
Stock CRLBF logo
Cresco Labs Inc.

OTC:CRLBF

CRLBF Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

CRLBF Stock Data

675.05M
170.74M
0.6%
7.97%
Medicinal and Botanical Manufacturing
Manufacturing
Link
US
Chicago

About CRLBF

cresco labs llc is an illinois medical cannabis company, licensed to develop and operate medical cannabis cultivation centers in police districts 5, 9 and 21, according to illinois’ office of the governor. cresco labs exceeded the state’s rigorous qualifying standards, receiving the highest scores of any cultivation center applicant to obtain three of 18 total awarded cultivation licenses as part of the illinois medical cannabis pilot program.